BCC Research
View Existing Reports | Report Subscriptions | Upcoming Reports | Press Room
 

Biotechnology

Therapeutics and Diagnostics for Women's Disorders  

Report Code: BIO043D, Published: March 2009

 
Also see:
  BIO043C - May 2005
  BIO043B - January 2001

 
 

The Report:

  • The U.S. market for therapeutics and diagnostics for women’s disorders was worth $29.9 billion in 2008. This should increase to $50.0 billion in 2013, for a compound annual growth rate (CAGR) of 10.9%.
  • The rheumatoid arthritis and osteoporosis segment has the largest share of the market, generating $10.6 billion in 2008. This is expected to grow at a CAGR of 11.5% to reach $18.2 billion in 2013.
  • Reproductive related therapies and diagnostics currently have the second largest market share, worth $5.9 billion in 2008. This should reach $7.5 billion in 2013, for a CAGR of 5.0%.

 

Report Code: BIO043D, Published: March 2009, Analyst: Melissa Elder

 
 

   Bookmark and Share


   

 Visit the Table of Contents  to purchase the report or to  download the introduction  chapter for free.



All transactions on our web site are conducted on a Secure SSL Server.
Copyright 2010 © All rights reserved.   About Us | Contact Us | Careers | Privacy Policy  |  Site Map |  XML Map